DP

David Park, JD

Vice President, Business Development

Advanced Cellular Dynamics

Advanced Cellular Dynamics Pipeline

DrugIndicationPhase
ACD-101Relapsed/Refractory B-cell Non-Hodgkin LymphomaPhase 1/2
ACD-201Moderate-to-Severe Crohn's DiseasePhase 1
ACD-301Solid TumorsPreclinical